127 related articles for article (PubMed ID: 9425315)
1. Investigations using photo affinity labeled analogues confirm the binding between sCD4 and the PND of HIV-1, MN.
Dettin M; Scarinci C; Seraglia R; Di Bello C
Biochem Biophys Res Commun; 1997 Dec; 241(2):584-8. PubMed ID: 9425315
[TBL] [Abstract][Full Text] [Related]
2. Binding to CD4 of synthetic peptides patterned on the principal neutralizing domain of the HIV-1 envelope protein.
Autiero M; Abrescia P; Dettin M; Di Bello C; Guardiola J
Virology; 1991 Dec; 185(2):820-8. PubMed ID: 1720590
[TBL] [Abstract][Full Text] [Related]
3. Structural studies on synthetic peptides from the principal neutralizing domain of HIV-1 gp120 that bind to CD4 and enhance HIV-1 infection.
Dettin M; De Rossi A; Autiero M; Guardiola J; Chieco-Bianchi L; Di Bello C
Biochem Biophys Res Commun; 1993 Mar; 191(2):364-70. PubMed ID: 8460995
[TBL] [Abstract][Full Text] [Related]
4. Phage randomization in a charybdotoxin scaffold leads to CD4-mimetic recognition motifs that bind HIV-1 envelope through non-aromatic sequences.
Li C; Dowd CS; Zhang W; Chaiken IM
J Pept Res; 2001 Jun; 57(6):507-18. PubMed ID: 11437954
[TBL] [Abstract][Full Text] [Related]
5. Simple methods for monitoring HIV-1 and HIV-2 gp120 binding to soluble CD4 by enzyme-linked immunosorbent assay: HIV-2 has a 25-fold lower affinity than HIV-1 for soluble CD4.
Moore JP
AIDS; 1990 Apr; 4(4):297-305. PubMed ID: 2190604
[TBL] [Abstract][Full Text] [Related]
6. Is the V3 loop involved in HIV binding to CD4?
Dettin M; Ferranti P; Scarinci C; Picariello G; Di Bello C
Biochemistry; 2003 Aug; 42(30):9007-12. PubMed ID: 12885233
[TBL] [Abstract][Full Text] [Related]
7. Beta-turn Phe in HIV-1 Env binding site of CD4 and CD4 mimetic miniprotein enhances Env binding affinity but is not required for activation of co-receptor/17b site.
Dowd CS; Leavitt S; Babcock G; Godillot AP; Van Ryk D; Canziani GA; Sodroski J; Freire E; Chaiken IM
Biochemistry; 2002 Jun; 41(22):7038-46. PubMed ID: 12033937
[TBL] [Abstract][Full Text] [Related]
8. Dissociation of gp120 from HIV-1 virions induced by soluble CD4.
Moore JP; McKeating JA; Weiss RA; Sattentau QJ
Science; 1990 Nov; 250(4984):1139-42. PubMed ID: 2251501
[TBL] [Abstract][Full Text] [Related]
9. Heparin and its derivatives bind to HIV-1 recombinant envelope glycoproteins, rather than to recombinant HIV-1 receptor, CD4.
Harrop HA; Rider CC
Glycobiology; 1998 Feb; 8(2):131-7. PubMed ID: 9451022
[TBL] [Abstract][Full Text] [Related]
10. The potential molecular targets of marine sulfated polymannuroguluronate interfering with HIV-1 entry. Interaction between SPMG and HIV-1 rgp120 and CD4 molecule.
Meiyu G; Fuchuan L; Xianliang X; Jing L; Zuowei Y; Huashi G
Antiviral Res; 2003 Jul; 59(2):127-35. PubMed ID: 12895696
[TBL] [Abstract][Full Text] [Related]
11. A functional, discontinuous HIV-1 gp120 C3/C4 domain-derived, branched, synthetic peptide that binds to CD4 and inhibits MIP-1alpha chemokine binding.
Howie SE; Fernandes ML; Heslop I; Hewson TJ; Cotton GJ; Moore MJ; Innes D; Ramage R; Harrison DJ
FASEB J; 1999 Mar; 13(3):503-11. PubMed ID: 10064617
[TBL] [Abstract][Full Text] [Related]
12. Neutralization of human immunodeficiency virus type 1 by sCD4-17b, a single-chain chimeric protein, based on sequential interaction of gp120 with CD4 and coreceptor.
Dey B; Del Castillo CS; Berger EA
J Virol; 2003 Mar; 77(5):2859-65. PubMed ID: 12584309
[TBL] [Abstract][Full Text] [Related]
13. A rationally designed synthetic mimic of the discontinuous CD4-binding site of HIV-1 gp120.
Franke R; Hirsch T; Eichler J
J Recept Signal Transduct Res; 2006; 26(5-6):453-60. PubMed ID: 17118792
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of soluble CD4 binding to cells expressing human immunodeficiency virus type 1 envelope glycoprotein.
Dimitrov DS; Hillman K; Manischewitz J; Blumenthal R; Golding H
J Virol; 1992 Jan; 66(1):132-8. PubMed ID: 1727475
[TBL] [Abstract][Full Text] [Related]
15. Conformational changes of gp120 in epitopes near the CCR5 binding site are induced by CD4 and a CD4 miniprotein mimetic.
Zhang W; Canziani G; Plugariu C; Wyatt R; Sodroski J; Sweet R; Kwong P; Hendrickson W; Chaiken I
Biochemistry; 1999 Jul; 38(29):9405-16. PubMed ID: 10413516
[TBL] [Abstract][Full Text] [Related]
16. Mode of action for linear peptide inhibitors of HIV-1 gp120 interactions.
Biorn AC; Cocklin S; Madani N; Si Z; Ivanovic T; Samanen J; Van Ryk DI; Pantophlet R; Burton DR; Freire E; Sodroski J; Chaiken IM
Biochemistry; 2004 Feb; 43(7):1928-38. PubMed ID: 14967033
[TBL] [Abstract][Full Text] [Related]
17. Competition of HLA-DR and a beta 2 domain peptide for HIV envelope glycoprotein gp120 binding to CD4.
Autiero M; Houlgatte R; Martin M; Auffray C; Guardiola J; Piatier-Tonneau D
Int Immunol; 1995 Feb; 7(2):191-7. PubMed ID: 7734415
[TBL] [Abstract][Full Text] [Related]
18. Sulfated polyanions prevent HIV infection of lymphocytes by disruption of the CD4-gp120 interaction, but do not inhibit monocyte infection.
Lynch G; Low L; Li S; Sloane A; Adams S; Parish C; Kemp B; Cunningham AL
J Leukoc Biol; 1994 Sep; 56(3):266-72. PubMed ID: 7521897
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of glycoprotein gp120 dissociation from the envelope glycoprotein complex of human immunodeficiency virus type 1 by soluble CD4 and CD4 peptide derivatives: implications for the role of the complementarity-determining region 3-like region in membrane fusion.
Berger EA; Lifson JD; Eiden LE
Proc Natl Acad Sci U S A; 1991 Sep; 88(18):8082-6. PubMed ID: 1896455
[TBL] [Abstract][Full Text] [Related]
20. The C4 region as a target for HIV entry inhibitors--NMR mapping of the interacting segments of T20 and gp120.
Moseri A; Biron Z; Arshava B; Scherf T; Naider F; Anglister J
FEBS J; 2015 Dec; 282(24):4643-57. PubMed ID: 26432362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
